FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1830 June 23, 1994 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: Treatment of hematologic cancers has recently focused on the use of tretinoin (retinoic acid), the vitamin A derivative, and similar retinoids to induce differentiation of immature neoplastic cells¹. Unfortunately, severe side effects have been documented². The present report describes the use of beta carotene, a vitamin A precursor, in a patient with chronic lymphocytic leukemia and associated cutaneous T-cell lymphoma. Beta carotene was chosen because it is a remarkably safe substance³.

A 65-year-old man reporting intractable pruritus was examined in April 1993, and scattered erythematous macules were noted. Chronic lymphocytic (T-cell) leukemia had been . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.